Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

6.200 USD +0.300 (+5.08%)
Official Closing Price Updated: 7:54 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,863,500
Open 6.000
Bid (Size) 5.720 (1)
Ask (Size) 6.350 (1)
Prev. Close 5.900
Today's Range 5.510 - 6.260
52wk Range 2.710 - 8.870
Shares Outstanding 130,544,498
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit
Cerus Corporation (Nasdaq: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to... 
From Business Wire News Releases
Cerus Corporation Announces Record Fourth Quarter and Full Year 2020 Financial Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and year ended December 31, 2020. 
From Business Wire News Releases

Performance

YTD
-10.66%
-10.66%
1 Month
-17.33%
-17.33%
3 Month
-15.53%
-15.53%
6 Month
+7.27%
+7.27%
1 Year
+12.93%
+12.93%

More News

Read More
Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China
From Business Wire News Releases
Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
From Business Wire News Releases
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
From Business Wire News Releases
Sum Up The Parts: FYC Could Be Worth $75
Tags ETFs
From ETF Channel
Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue
From Business Wire News Releases
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Tags RNLX Health Care Covid/19
From Benzinga
Cerus’ Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelet
From Business Wire News Releases
A Preview Of Cerus's Earnings
Tags Market News CERS Benzinga
From Benzinga
Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.